EMR Update 7 - HIPAA, HITECH, and Protecting Your Patients' Information This Issue: What is data-at-rest vs data-in-motion? What do the new HITECH Act provisions mean to your medical practice? What are potential penalties for violating the HIPAA regulations? What proactive measures can you take to protect yourself and your practice? [smart_track_player url="http://mptaudio.s3.amazonaws.com/$emed$podcast/MPT_podcast_7.mp3" title="MPT Podcast 7- HIPAA, HITECH, and Protecting Your Patients' Information" ]

EMR Update 6 - eRx and PQRI: Are Your Leaving Money on the Table? This Issue: How can your practice qualify for 'Stimulus Bill' financial incentives? ePrescribing(eRx) & PQRI - what bonuses can you expect for each? How do you make a claim? Find out about PQRI Toolset, a tool that can help you claim bonus payments (Note: MPT has a financial interest in Protodrone LLC, creator of PQRI Toolset) [smart_track_player url="http://mptaudio.s3.amazonaws.com/$emed$podcast/MPT_podcast_6.mp3" title="MPT Podcast 6-ePrescribing, PQRI, and ARRA Incentives" ]

So, you're thinking about getting rid of paper charts and switching to an EMR system. Is it really worth the cost and aggravation? Will it bring your people together or tear them apart? In the first of our EMR Video Tutorial series, we introduce the concept of "Going Paperless". We take a brief overview of the thought process which led a practice to take the plunge and move forward with EMR implementation. In subsequent videos, we'll break that process down into digestible phases. Get Adobe Flash player

Washington Update - Latest Healthcare & Regulatory Law from Alan Reider of Arnold & Porter LLP This Issue: The Federal Physician Payment Sunshine Act Feds and States cracking down on improper relationships between physicians and drug companies What medical practices should be aware of Can accepting a pen from a rep get you in legal hot water? [smart_track_player url="http://mptaudio.s3.amazonaws.com/$emed$podcast/MPT_podcast_5.mp3" title="MPT Podcast 5-Washington Update: Relationships between MDs and Pharma Scrutinized" ]